March 4, 2010 (FinancialWire) — Repligen Corp. (NASDAQ: RGEN) said that it has acquired the assets of BioFlash Partners, LLC, including a technology platform for the production of pre-packed, “plug and play” chromatography columns.

Acccording to Repligen, the patented technology enables economical production of chromatography columns in a format that is ready for use in the production of a range of biopharmaceuticals including monoclonal antibodies, vaccines and recombinant proteins.

The terms of the acquisition include an upfront payment of $1.8 million, a contingent milestone and royalties based on product sales.

Repligen said that a product offering based on this technology is being launched this week at the IBC Biopharmaceutical Development and Production conference under the brand name Opus.

The Opus products are offered in a range of column diameters and bed heights and can be pre-packed with commercially available chromatography resins including immobilized Protein A.

Repligen said that “Plug and play” chromatography columns have the potential to improve the speed of process development and reduce the cost of biopharmaceutical manufacturing by decreasing the time associated with set-up, cleaning and validation of traditional manufacturing technologies.

Massachusetts-based Repligen is a biopharmaceutical company focused on the development of novel therapeutics for neurological disorders.

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.